Literature DB >> 12861397

Tubular adenoma and intramucosal intestinal-type adenocarcinoma of the stomach: what are the pathobiological differences?

Satoru Kase1, Mitsuhiko Osaki, Soichiro Honjo, Hironobu Adachi, Hisao Ito.   

Abstract

BACKGROUND: The concept of human early gastric cancer has discrepancies among pathologists worldwide. Recently, a novel morphological classification of gastrointestinal intramucosal neoplasias was proposed and conceptual differences have gradually decreased. However, there are few studies on the differences of pathobiological properties among the intraepithelial neoplasms. The aim of the present study was to clarify the clinicopathological significance of gastric intramucosal tumors from the pathobiological viewpoint.
METHODS: This study analyzed 70 tubular adenomas (TAs) with mild or moderate atypia and 52 intramucosal intestinal-type adenocarcinomas (IMACs) of the stomach from the viewpoint of the apoptotic index (AI), Ki-67 labeling index (KI), and intratumoral microvessel density (IMVD), using immunohistochemistry and the terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick-end labeling (TUNEL) method. We also examined the expression of P53 and thymidine phosphorylase (dThdPase).
RESULTS: The mean AI was significantly higher and the mean KI and IMVD were significantly lower in the TAs than in the IMACs (P < 0.05, P < 0.001, and P < 0.01, respectively). AI and IMVD showed a negative correlation in TAs and IMACs (TAs; P = 0.015; r = 0.28; IMACs; P = 0.006; r = 0.41). dThdPase and nuclear P53 expression were significantly higher in the IMACs than in the TAs (P < 0.05, P < 0.01). Mean IMVD was significantly higher in dThdPase-positive tumors than in the negative ones (P < 0.01, P < 0.01) in both TAs and IMACs.
CONCLUSION: IMACs possess higher proliferative activity of tumor cells, with a vascular-rich microenvironment, than TAs. This might reflect the pathobiological differences between gastric IMACs and TAs, and could also provide useful information on indications for gastric endoscopic mucosal resection for IMACs as has been recommended by the Japanese Gastric Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861397     DOI: 10.1007/s10120-002-0210-7

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  4 in total

1.  Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions.

Authors:  Bin Dong; Yu-Quan Xie; Ke Chen; Tao Wang; Wei Tang; Wei-Cheng You; Ji-You Li
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Differential expression of basement membrane type IV collagen alpha chains in gastric intramucosal neoplastic lesions.

Authors:  Yoshifumi Baba; Ken-Ichi Iyama; Koei Ikeda; Shinji Ishikawa; Naoko Hayashi; Nobutomo Miyanari; Yumi Honda; Yoshikazu Sado; Yoshifumi Ninomiya; Hideo Baba
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

3.  Gene expression profiling reveals sequential changes in gastric tubular adenoma and carcinoma in situ.

Authors:  Chang-Hee Lee; Seung-Hyun Bang; Seung-Koo Lee; Kyu-Young Song; In-Chul Lee
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

4.  Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma.

Authors:  Xue-Quan Yao; Fu-Kun Liu; Jie-Shou Li; Xiao-Ping Qi; Bo Wu; Hong-Lin Yin; Heng-Hui Ma; Qun-Li Shi; Xiao-Jun Zhou
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.